BURLINGTON, Mass., Aug. 1 /PRNewswire-FirstCall/ --
Palomar Medical Technologies Inc (Nasdaq: PMTI) today announced that it
received clearance from the U.S. Food and Drug Administration (FDA) to sell
and market a new handpiece for the Palomar EsteLux(TM) light-based system for
"permanent hair reduction" for all skin types, including tanned skin. The
Company will now have the Palomar LuxRs(TM) handpiece along with its other
EsteLux system handpieces.
(Photo: http://www.newscom.com/cgi-bin/prnh/20000308/PMTILOGO )
The LuxRs red light filtered handpiece expands the EsteLux system's
treatment capabilities greatly by allowing for permanent hair reduction on all
skin types. With a unique combination of optics and energy levels, the new
LuxRs handpiece selectively targets melanin in the hair follicle. The EsteLux
system is the most versatile and economic cosmetic device on the market.
A customer who has been receiving treatments with the EsteLux system
commented, "Having been treated with the EsteLux system, I must say that the
advances demonstrated are extremely impressive. With only a limited number of
treatments to my face, I have substantially reduced my shaving due to the
reduction in both amount and coarseness of the hairs. The EsteLux treatments
on my back are also impressive. There is very little hair left, and what hair
remains is so fine that it is hardly noticeable. My experience with Palomar's
products has been wonderful. I would recommend the EsteLux to anyone who is
serious about hair removal."
As recently announced, sales of Palomar products continue to be impressive
during the historically slow summer months. In addition to the LuxRs
handpiece, the other EsteLux system handpieces include the LuxY(TM) yellow
light filtered handpiece for fast removal of hair and pigmented lesions on
lighter skin types; the LuxG(TM) green light filtered handpiece for pigmented
and vascular lesion treatments; and the LuxR(TM) red light filtered handpiece
for fast removal of hair on all skin types, including tanned skin.
To get more information regarding Palomar and its products, please visit
Palomar's website at http://www.palmed.com. Also, to continue to receive the most
up-to-date information and latest news on Palomar as it happens, sign up to
receive automatic e-mail alerts by going to the E-mail alerts page in the
Investor Relations' section of the web site.
With the exception of the historical information contained in this
release, the matters described herein contain forward-looking statements,
including but not limited to statements relating to new markets, development
and introduction of new products, and financial projections that involve risk
and uncertainties that may individually or mutually impact the matters herein,
and cause actual results, events and performance to differ materially from
such forward-looking statements. These risk factors include, but are not
limited to, results of future operations, technological difficulties in
developing or introducing new products, the results of future research, lack
of product demand and market acceptance for current and future products, the
effect of economic conditions, the impact of competitive products and pricing,
governmental regulations with respect to medical devices, including whether
FDA clearance will be obtained for future products, the results of litigation,
potential infringement of third-party intellectual property rights, and/or
other factors, which are detailed from time to time in the company's SEC
reports, including the report on Form 10-K for the year ended December 31,
2001 and the Company's quarterly reports on Form 10-Q. Readers are cautioned
not to place undue reliance on these forward-looking statements, which speak
only as of the date hereof. The company undertakes no obligation to release
publicly the result of any revisions to these forward-looking statements that
may be made to reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
Contacts: Paul S. Weiner
Palomar Medical Technologies Inc
781-993-2411
ir@palmed.com
SOURCE Palomar Medical Technologies Inc
 back to top
Related links:
http://www.palmed.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20000308/PMTILOGO
PRN Photo Desk, 888-776-6555 or 212-782-2840
Company News On-Call:
http://www.prnewswire.com/comp/107555.html
CONTACT:
Paul S. Weiner of Palomar Medical
Technologies Inc, +1-781-993- 2411, ir@palmed.com
|
